Home › NDC Lookup › Ingredients › Tolnaftate › 73352-0560-01
Tritolnacide S Tolnaftate .01 g/mL Solution, 15 mL — NDC 73352-0560-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Tritolnacide S Tolnaftate .01 g/mL Solution, 15 mL — NDC 73352-560-01 (Billing 73352-0560-01)

by Trifluent Pharma LLC · 15 mL in 1 BOTTLE, WITH APPLICATOR

This is a package of 15 mL of Tritolnacide S Tolnaftate .01 g/mL Solution from Trifluent Pharma LLC, marketed since Dec 2023 and currently FDA-listed. It is this product's only package size.

NDC 73352-0560-01
🏷️ FDA NDC (as labeled) 73352-560-01 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 73352-560-01 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
73352 labeler · 560 product · 01 package
Package marketed since
Dec 11, 2023
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
15 mL per package
Barcode (UPC-A, from the NDC)
3 7335256001 1
Medicaid fills, this package
24 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 73352-560-01
Product NDC 73352-560
11-digit billing NDC 73352056001
NCPDP billing unit ML — per mL (volume)
RxCUI 313423, 2679333
UNII 06KB629TKV
Application # M005
SPL Set ID b69ba7c9-03c1-4f5e-aa93-3ea1f2db15d8
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2023-12-11
Route TOPICAL
Dosage form SOLUTION
Substance TOLNAFTATE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 90150085002005
GCN Seq No 007341
GCN 30320
HICL code 003186
Ingredient (HICL) Tolnaftate
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q5
Therapeutic class — intermediate (HIC2) Agents Acting Principally On The Skin
HIC3 code Q5F
Therapeutic class — specific (HIC3) Topical Antifungals
AHFS code 84:04.08.40
AHFS class Thiocarbamates(Skin And Mucous Membrane)
FDB label name TRITOLNACIDE S 1% SOLUTION
FDB brand name Tritolnacide S
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 007341
  • GCN: 30320
  • GPI-14 (Medi-Span): 90150085002005
  • HICL (First Databank): 003186
  • AHFS class code: 84:04.08.40
  • RxCUI (RxNorm): 313423
Why two NDCs? The FDA registers this code as 73352-560-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 73352-0560-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Other antifungals for topical use class.

Drug family (ATC) Other antifungals for topical use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name TRITOLNACIDE S 1% SOLUTION Ingredient Tolnaftate
📖 What it is MedlinePlus · NLM

Tolnaftate stops the growth of fungi that cause skin infections, including athlete's foot, jock itch, and ringworm. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It treats fungal skin infections like athlete's foot, ringworm and, in some products, jock itch. Many products also help prevent athlete's foot. Some are made for skin around the n...
  • Wash and dry the area well, then apply a thin layer. Most products are used twice a day, morning and night. The length of use varies, often 4 weeks for athlete's foot and ringworm,...
  • The main one is skin irritation. If that happens, stop using it and talk to a doctor.
  • Call if you see no improvement within 4 weeks for athlete's foot or ringworm, or 2 weeks for jock itch. Call if irritation develops. Call right away if anyone swallows it.
📖 Read our full Tolnaftate guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo $53.22 $798.27 / 15 ml
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
73352-0560-01 You're viewing this Main listing 15 mL in 1 BOTTLE, WITH APPLICATOR 2023-12-11 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Maximum Strength Antifungal Liquid 10 mg/mL 00363-2026-01 Walgreens 1 bottle — — FDA listed —
Antifungal Liquid 10 mg/mL 00363-4471-01 Walgreens 1 bottle — — FDA listed —
Antifungal Liquid Maximum Strength 10 mg/mL 00363-7998-01 Walgreens 1 bottle — — FDA listed —
Antifungal Solution Maximum Strength 10 mg/mL 11822-9600-01 Rite 1 bottle — — Discontinued —
Meijer Maximum Strength Athletes Foot Antifungal 10 mg/g 23667-0811-01 Formulated 150 g — — Discontinued —
Signature Care Athletes Foot Antifungal 10 mg/g 23667-0813-01 Formulated 150 g — — Discontinued —
Up and Up Soothing Antifungal 10 mg/g 23667-0816-01 Formulated 150 g — — Discontinued —
ProClearz Maximum Strength Fungal Shield Brush-on Antifungal 10 mg/mL 29784-0181-02 Rooftop 1 bottle — — FDA listed —
Proclearz Professional Fungal Shield 10 mg/mL 29784-0184-01 Rooftop 1 bottle — — FDA listed —
Antifungal Liquid 10 mg/mL 36800-0399-01 TopCo 1 bottle — — FDA listed —
CLARUS Antifungal 1 g/100mL 44577-0002-01 Clinical 15 ml — — FDA listed —
CLARUS AC Antifungal Solution 10 mg/g 44577-0128-00 Clinical 15 g — — FDA listed —
Formula 3 10 mg/mL 49406-0003-15 The 1 bottle — — FDA listed —
Formula 7 - The Solution 1 g/100g 49406-0007-15 The 15 g — — FDA listed —
Hi Vetic 1 g/100mL 49873-0050-02 Sato 1 bottle — — FDA listed —
Silka Antifungal 1 g/100mL 50066-0085-01 Genomma 1 bottle — — FDA listed —
Nail Renovar Plus 1 g/100mL 50405-0030-02 SOHM, 15 ml — — FDA listed —
CIDACIN Antifungal Treatment 1 g/100mL 51151-0000-01 Pedicis 1 bottle — — FDA listed —
Maximum Strength Antifungal Liquid .3 g/30mL 51316-0898-00 CVS 30 ml — — FDA listed —
Toe Area Treatment 10 mg/mL 51316-0981-01 CVS 1 bottle — — FDA listed —
Fungicure Anti-Fungal Liquid 8.65 mg/mL 52389-0298-30 Kobayashi 1 bottle — — FDA listed —
Antifungal Liquid 10 mg/mL 55319-0538-01 Family 1 bottle — — FDA listed —
Fungi Nail Toe and Foot 10 mg/mL 55505-0177-26 Kramer 1 bottle — — FDA listed —
Fungi Nail Anti-Fungal Pen 1 g/100mL 55505-0193-51 Kramer 1 tube — — FDA listed —
Opti-Nail 2-in-1 1 g/100mL 55505-0219-67 Kramer 5 ml — — FDA listed —
Antifungal Liquid 10 mg/mL 56104-0902-01 Premier 1 bottle — — FDA listed —
Mycozyl AL .3 g/30mL 59088-0443-03 PureTek 30 ml — — FDA listed —
Micotrin AL .3 g/30mL 59088-0477-03 PureTek 30 ml — — FDA listed —
Micomitin Antifungal .3 g/30mL 59088-0640-03 PureTek 30 ml — — FDA listed —
Nail Renew 1 g/100mL 62858-0101-51 Nailrenew 1 bottle — — FDA listed —
Maximum Strength Antifungal Liquid 10 mg/mL 67091-0753-30 WinCo 1 bottle — — Discontinued —
Antifungal Liquid 10 mg/mL 70000-0680-01 LEADER/Cardinal 1 bottle — — FDA listed —
Antifungal Liquid 10 mg/mL 70000-0745-01 LEADER/ 1 bottle — — FDA listed —
Liquid Antifungal Treatment 10 mg/mL 72446-0012-01 Hudson 1 bottle — — FDA listed —
Maximum Strength Antifungal Liquid 10 mg/mL 72446-0013-01 Hudson 1 bottle — — FDA listed —
Novonail Solution 1 g/100mL 72839-0507-01 Derma 13.3 ml — — FDA listed —
Dermatool Fungal Nail Treatment 1 g/100mL 72839-0510-01 Derma 1 bottle — — FDA listed —
Tritolnacide S .01 g/mLthis 73352-0560-01 Trifluent 15 ml — — FDA listed —
Maximum Strength Antifungal Liquid 10 mg/mL 79481-0660-01 Meijer 1 bottle — — FDA listed —
Antifungal Liquid 10 mg/mL 79903-0256-30 Wal-Mart 1 bottle — — FDA listed —
Antifungal Liquid 10 mg/mL 79903-0394-01 Wal-Mart 1 bottle — — FDA listed —
Maximum Strength Antifungal Liquid 10 mg/mL 81522-0077-01 FSA 1 bottle — — FDA listed —
Antifungal Liquid 10 mg/mL 82442-0956-01 Target 1 bottle — — FDA listed —
Antifungal Liquid 10 mg/mL 82442-0998-01 Target 1 bottle — — FDA listed —
Maximum Strength Antifungal Liquid 10 mg/mL 83324-0301-01 Chain 1 bottle — — FDA listed —
Toe Fungus 1 g/100mL 83837-0001-01 Imperial 75 ml — — FDA listed —
Athletes Foot 1 g/100mL 83837-0002-01 Imperial 75 ml — — FDA listed —
Nailtific Nighttime Antifungal Renewal Pen Refill .06 g/6mL 84167-0023-31 Guangzhou 1 bottle — — FDA listed —
APUREE Nailtific Extra-Max Strength Nighttime Antifungal 1 g 84167-0479-02 Guangzhou 1 vial — — FDA listed —
Nail Lab Fungomer Nailelixir 1 g/100mL 84222-0002-01 Foshan 50 ml — — Discontinued —
TOENAIL FUNGUS TREATMENT MAXIMUM STRENGTH Liquid 1 g/100mL 84614-0002-01 Shenzhen 2 bottles — — FDA listed —
Dermatool Fungal Nail Treatment 1 g/100mL 84728-0510-01 Papalo 1 bottle — — FDA listed —
Nekvnro FUNGAL NAIL TREATMENT Kit 1 g/100mL 84844-0019-01 Guoyu 2 bottles — — Discontinued —
Ukova Foot Odor Probiotic 1 g/100mL 84867-0011-01 Jiashen 30 ml — — FDA listed —
UKVOA Toenail Fungus Treatment 1 g/100mL 84867-0012-01 Jiashen 30 ml — — FDA listed —
Alveora NAIL FUNGUS TREATMENT 1 g/100mL 85248-0033-01 Jiangxi 30 ml — — FDA listed —
Dermfree Fungi Nail 1 g/100mL 85248-0037-01 Jiangxi 15 ml — — FDA listed —
Cndanting Multi-Purpose Nail Repair 1 g/100mL 85248-0040-01 Jiangxi 30 ml — — Discontinued —
BeamBalm FUNGL NAIL 1 g/100mL 85248-0047-01 Jiangxi 4 ml — — FDA listed —
BeamBalm ANTIFUNGAL NAIL 1 g/100mL 85248-0048-01 Jiangxi 11 ml — — Discontinued —
Skapemed Skin Repair 1 g/100mL 85248-0054-01 Jiangxi 50 ml — — FDA listed —
Healmusz Fungi Nail 1 g/100mL 85248-0057-01 Jiangxi 15 ml — — FDA listed —
HEALMUSZ Multi-PurposeTreatment 1 g/100mL 85248-0058-01 Jiangxi 30 ml — — FDA listed —
Reinreude Multi-Purpose Treatment 1 g/100mL 85248-0072-01 Jiangxi 30 ml — — FDA listed —
Natuheal Multi -Purpose Treatment 1 g/100mL 85248-0081-01 Jiangxi 30 ml — — FDA listed —
Ourui One Fungal Nail Treatment 1 g/100mL 85248-0084-01 Jiangxi 2 bottles — — FDA listed —
PUVIDA Helps WITH NAGELPILZ 1 g/100mL 85248-0089-01 Jiangxi 2.5 ml — — FDA listed —
FIobow FUNGAL NAIL TREATMENT 1 g/100mL 85248-0095-01 Jiangxi 30 ml — — FDA listed —
Serynth Fungi Nail 1 g/100mL 85248-0108-01 Jiangxi 15 ml — — FDA listed —
Serynth Helps With Fungal Nail 1 g/100mL 85248-0109-01 Jiangxi 2.5 ml — — FDA listed —
Dermfree Helps With Nagelpilz 1 g/100mL 85248-0115-01 Jiangxi 4 ml — — FDA listed —
Folupia Fungal Nail Renewal 1 g/100mL 85248-0148-01 Jiangxi 30 ml — — FDA listed —
Tolfyra .3 g/30mL 85477-0331-01 Oncora 30 ml — — FDA listed —
Nail Fungus Treatment 1 g/100mL 85834-0001-01 Shenzhen 30 ml — — Discontinued —
Cureforte Anti Fungal Foot Care 10 mg/mL 85884-0252-02 STEEL 1 bottle — — FDA listed —
zourunan MULTI-PURPOS TREATMENT 1 g/100mL 87083-0001-01 Guchutang 30 ml — — FDA listed —
Dr. Luke FUNGAL NAIL RENEWAL 1 g/100mL 87147-0005-01 DANOUS 30 ml — — Discontinued —
nail fungus treatment 1 mg/100mg 87770-0003-01 Guangzhou 30 mg — — FDA listed —
EZBIORT 1% Tolnaftate Nail Essence with Biotin .01 g/mL 85304-0032-01 Guangzhou 2 bottles — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2023
On the market since
Dec 2023
📍
2026
Currently FDA-listed
3 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII H4N855PNZ1
    Alpha-tocopherol is a form of vitamin E, a fat-soluble antioxidant derived from natural or synthetic sources. In medicines, it prevents oils and fats from breaking down and becoming rancid, protecting the product's stability and shelf life.
  • UNII REK4960K2U
    Butylated hydroxyanisole is a synthetic preservative that prevents oils and fats in medicines from spoiling or becoming rancid. It keeps the medicine stable and extends its shelf life.
  • UNII 1P9D0Z171K
    BHT is a synthetic antioxidant that prevents fats and oils in medicines from breaking down and becoming rancid. It helps keep the product stable and effective during storage.
  • UNII 3QPI1U3FV8
    A preservative derived from benzoic acid that prevents bacterial and fungal growth in medicines. It helps extend shelf life and maintain product safety during storage and use.
  • UNII 14255EXE39
    Ethylparaben is a preservative, a chemical that stops bacteria and mold from growing in the medicine. It keeps the product safe and effective throughout its shelf life.
  • UNII 0QQJ25X58G
    Isobutylparaben is a preservative derived from para-hydroxybenzoic acid. It prevents bacterial and fungal growth in medicines, extending shelf life and maintaining product safety during storage.
  • UNII 724GKU717M
    Jojoba oil is a natural liquid wax extracted from jojoba plant seeds. It's used in medicines as an emollient and lubricant to soften and smooth the product, and sometimes as a carrier or penetration enhancer.
  • UNII A2I8C7HI9T
    Methylparaben is a preservative derived from benzoic acid that prevents growth of bacteria, fungi, and mold in medicines. It extends the product's shelf life and maintains safety during storage.
  • UNII T5L8T28FGP
    Mineral oil is a clear, odorless liquid derived from crude oil. It acts as a lubricant and emollient in medications, helping pills slide smoothly during manufacturing and aiding moisture retention in topical products.
  • UNII 7D0CGR40U1
    A natural oil extracted from oregano leaves, used as a flavoring agent and preservative in medicines. It adds taste and may help protect the product from degradation.
  • UNII HIE492ZZ3T
    Phenoxyethanol is a synthetic preservative and antimicrobial agent used to prevent bacterial and fungal growth in medicines and cosmetic products, extending shelf life and maintaining product safety.
  • UNII Z8IX2SC1OH
    Propylparaben is a chemical preservative used to prevent bacterial and fungal growth in medicines and personal care products. It helps extend shelf life and maintain product safety during storage.
  • UNII 65UEH262IS
    Safflower oil is a plant-based oil extracted from safflower seeds. It's used in medicines as a solvent and carrier to help dissolve or suspend active ingredients, and sometimes as an emollient to improve texture.

13 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesButylparaben, butylated hydroxyanisole, butylated hydroxytoluene, Carthamus tinctorius (safflower) seed oil, ethylparaben, isobutylparaben, methylparaben, Origanum vulgare (oregano) leaf oil, phenoxyethanol, propylparaben, Simmondsia chinensis (jojoba) seed oil, tocopherol, white mineral oil.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerTrifluent Pharma LLC
FDA applicationM005 (OTC MONOGRAPH DRUG)
Labeler code73352
First marketedDec 2023
Product typeHuman Otc Drug
Portfolio17 products on file

More NDCs from Trifluent Pharma LLC labeler code 73352

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Ask a Doctor or Pharmacist Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 28 words ▾

USES Treats most Athlete's Foot (Tinea Pedis), Jock Itch (Tinea Cruris), and Ringworm (Tinea Corporis) Relieves discomfort, irritation, cracking, scaly skin between the toes and itching, burning feet.

⏱️ Dosage and Administration 106 words ▾

DIRECTIONS Wash the affected area with soap and water and dry thoroughly Apply a thin layer of the product over the affected area twice daily (morning and night), or as directed by a doctor For Athlete's Foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes and change shoes and socks at least once daily Supervise children in the use of this product For Athlete's Foot and Ringworm, use daily for 4 weeks; for Jock Itch, use daily for 2 weeks. If condition persists longer, consult a doctor This product is not effective on the scalp or nails Wash hands after each use

⚠️ Warnings 112 words ▾

WARNINGS For external use only. Ask a doctor or pharmacist before use if you are Using any other medicines or cleansers on your skin When using this product Avoid contact with eyes: rinse immediately with cool tap water if contact occurs. Do not use for vaginal yeast Stop use and ask a doctor if Irritation occurs or if there is no improvement within 4 weeks (for Athlete's Foot or Ringworm) or within 2 weeks (for Jock Itch) Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away. Do not use on children under 2 years of age unless directed by a doctor.

🧪 Active Ingredient 4 words ▾

ACTIVE INGREDIENT Tolnaftate 1%

🧪 Inactive Ingredients 31 words ▾

INACTIVE INGREDIENTS Butylparaben, butylated hydroxyanisole, butylated hydroxytoluene, Carthamus tinctorius (safflower) seed oil, ethylparaben, isobutylparaben, methylparaben, Origanum vulgare (oregano) leaf oil, phenoxyethanol, propylparaben, Simmondsia chinensis (jojoba) seed oil, tocopherol, white mineral oil.

🎯 Purpose 2 words ▾

PURPOSE Antifungal

📄 Ask a Doctor or Pharmacist Before Use If 19 words ▾

Ask a doctor or pharmacist before use if you are Using any other medicines or cleansers on your skin

📄 When Using This Product 23 words ▾

When using this product Avoid contact with eyes: rinse immediately with cool tap water if contact occurs. Do not use for vaginal yeast

📄 Stop Use and Ask a Doctor If 30 words ▾

Stop use and ask a doctor if Irritation occurs or if there is no improvement within 4 weeks (for Athlete's Foot or Ringworm) or within 2 weeks (for Jock Itch)

📄 Keep Out of Reach of Children 35 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away. Do not use on children under 2 years of age unless directed by a doctor.

📄 Questions or Comments 6 words ▾

QUESTIONS OR COMMENTS? CALL (210) 944-6920

📄 Package Label / Principal Display Panel 42 words ▾

PRINCIPAL DISPLAY PANEL - 15 mL Bottle Label PRODUCT SHOULD BE ADMINISTERED UNDER THE SUPERVISION OF A LICENSED MEDICAL PRACTITIONER TRIFLUENT PHARMA ® TriTolnacide™ S ANTIFUNGAL SOLUTION TOLNAFTATE NDC 73352-560-01 0.5FL OZ (15 mL) PRINCIPAL DISPLAY PANEL - 15 mL Bottle Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q2 2025 – Q4 2025 · 3 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
24
Units reimbursed last 4 qtrs
1.4K
Gross reimbursed last 4 qtrs
$72.6K
Avg / prescription
$3,026.77
Avg / unit
$53.2179
Latest quarter Q4 2025
13Rx
Fee-for-service vs managed care ⓘ
100% MCO
Fee-for-service · 0 Rx Managed care · 24 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: no data reported WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: no data reported OH Pennsylvania: no data reported PA New Jersey: 1,365 units · 14.7 per 100k residents NJ Massachusetts: no data reported MA California: no data reported CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
14.714.7
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New Jersey 14.7 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Tritolnacide S (this brand).

Top reported reactions

Arthralgia17
Diarrhoea16
Fatigue13
Headache13
Rash Erythematous13
Blood Potassium Increased12
Bronchopulmonary Aspergillosis11

Age at onset

Child5
Adult15
Elderly14

Reporter sex

185 reports
Male · 50%
Female · 50%

Serious outcomes

Hospitalization64
Disabling9
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 18 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) ✓ Available
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Trifluent Pharma LLC. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Trifluent Pharma LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 73352-0555-01 · Trifluent 73352-0561-10 · Trifluent →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.